ArticleClinical pharmacology and therapeutics2025

Inhibition of OATP1B1/3 Rather Than UGT1A1 May Be the Major Cause of the Bilirubin Elevation After Atazanavir Administration.

Jin Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.